Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Ma

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic scoreJ Edeline, J-F Blanc, B Campillo-Gimenez, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 30, 2019
[Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance]F F Liu, D H Shen, H L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Potent and selective inhibitors of the proteasome: dipeptidyl boronic acidsJ Adams, M Behnke, S Chen, et al.
Genetics and Molecular Research : GMR|December 24, 2011
S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetesY-Y Zheng, X Xie, Y-T Ma, et al.
Zhonghua Yi Xue Za Zhi|February 24, 2016
[Current status regarding the cardiovascular disease-related risk levels among the hypertensive population of different ethnicities in Xinjiang Uygur Autonomous Region, China]M T Gai, Y T Ma, Y N Yang, et al.
British Journal of Cancer|March 23, 2018
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinomaD H Palmer, Y T Ma, M Peck-Radosavljevic, et al.
Genetics and Molecular Research : GMR|December 5, 2013
Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, ChinaJ Zhang, Y T Ma, X Xie, et al.
Tissue Antigens|February 7, 2015
Genetic polymorphisms of serum amyloid A1 and coronary artery disease riskX Xie, Y-T Ma, Y-N Yang, et al.
European Journal of Clinical Nutrition|March 19, 2015
Optimal waist-to-height ratio cutoff values for predicting cardio-metabolic risk in Han and Uygur adults in northwest part of ChinaC-H He, S Pan, Y-T Ma, et al.
Environmental Pollution (Barking, Essex : 1987)|June 29, 2026
Association of real-time noise exposure with rest-activity circadian rhythms and sleep health: a 7-day longitudinal measure among Hong Kong nurses with night-shiftsXueqiong Weng, Natalie H Y Tang, Julie Y T Ma, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic scoreJ Edeline, J-F Blanc, B Campillo-Gimenez, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 30, 2019
[Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance]F F Liu, D H Shen, H L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Potent and selective inhibitors of the proteasome: dipeptidyl boronic acidsJ Adams, M Behnke, S Chen, et al.
Genetics and Molecular Research : GMR|December 24, 2011
S323I polymorphism of the C5L2 gene was not identified in a Chinese population with familial combined hyperlipidemia or with type 2 diabetesY-Y Zheng, X Xie, Y-T Ma, et al.
Zhonghua Yi Xue Za Zhi|February 24, 2016
[Current status regarding the cardiovascular disease-related risk levels among the hypertensive population of different ethnicities in Xinjiang Uygur Autonomous Region, China]M T Gai, Y T Ma, Y N Yang, et al.
British Journal of Cancer|March 23, 2018
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinomaD H Palmer, Y T Ma, M Peck-Radosavljevic, et al.
Genetics and Molecular Research : GMR|December 5, 2013
Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, ChinaJ Zhang, Y T Ma, X Xie, et al.
Tissue Antigens|February 7, 2015
Genetic polymorphisms of serum amyloid A1 and coronary artery disease riskX Xie, Y-T Ma, Y-N Yang, et al.
European Journal of Clinical Nutrition|March 19, 2015
Optimal waist-to-height ratio cutoff values for predicting cardio-metabolic risk in Han and Uygur adults in northwest part of ChinaC-H He, S Pan, Y-T Ma, et al.
Environmental Pollution (Barking, Essex : 1987)|June 29, 2026
Association of real-time noise exposure with rest-activity circadian rhythms and sleep health: a 7-day longitudinal measure among Hong Kong nurses with night-shiftsXueqiong Weng, Natalie H Y Tang, Julie Y T Ma, et al.
Pageof 6